HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:DOC • US42250P1030

16.705 USD
+0.02 (+0.15%)
Last: Feb 6, 2026, 01:20 PM
Fundamental Rating

4

DOC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 124 industry peers in the Diversified REITs industry. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DOC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year DOC was profitable.
  • In the past year DOC had a positive cash flow from operations.
  • Each year in the past 5 years DOC has been profitable.
  • DOC had a positive operating cash flow in each of the past 5 years.
DOC Yearly Net Income VS EBIT VS OCF VS FCFDOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.35%, DOC is in line with its industry, outperforming 45.16% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 0.94%, DOC is in line with its industry, outperforming 44.35% of the companies in the same industry.
  • DOC has a Return On Invested Capital (2.24%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.05%.
Industry RankSector Rank
ROA 0.35%
ROE 0.94%
ROIC 2.24%
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
DOC Yearly ROA, ROE, ROICDOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • DOC has a Profit Margin (2.50%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of DOC has declined.
  • Looking at the Operating Margin, with a value of 19.31%, DOC is in line with its industry, outperforming 45.97% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DOC has grown nicely.
  • Looking at the Gross Margin, with a value of 60.00%, DOC is doing worse than 66.94% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DOC has grown nicely.
Industry RankSector Rank
OM 19.31%
PM (TTM) 2.5%
GM 60%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
DOC Yearly Profit, Operating, Gross MarginsDOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOC is destroying value.
  • The number of shares outstanding for DOC has been reduced compared to 1 year ago.
  • DOC has more shares outstanding than it did 5 years ago.
  • DOC has a worse debt/assets ratio than last year.
DOC Yearly Shares OutstandingDOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
DOC Yearly Total Debt VS Total AssetsDOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • DOC has an Altman-Z score of 0.32. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
  • DOC has a Altman-Z score of 0.32. This is in the lower half of the industry: DOC underperforms 61.29% of its industry peers.
  • DOC has a debt to FCF ratio of 6154.93. This is a negative value and a sign of low solvency as DOC would need 6154.93 years to pay back of all of its debts.
  • DOC has a Debt to FCF ratio of 6154.93. This is in the better half of the industry: DOC outperforms 61.29% of its industry peers.
  • DOC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
  • DOC has a Debt to Equity ratio (1.27) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 6154.93
Altman-Z 0.32
ROIC/WACC0.35
WACC6.36%
DOC Yearly LT Debt VS Equity VS FCFDOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
  • With a Current ratio value of 0.48, DOC is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.48, DOC is doing worse than 80.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
DOC Yearly Current Assets VS Current LiabilitesDOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for DOC have decreased by 0.00% in the last year.
  • DOC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.06% yearly.
  • Looking at the last year, DOC shows a small growth in Revenue. The Revenue has grown by 4.52% in the last year.
  • The Revenue has been growing by 11.40% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%

3.2 Future

  • Based on estimates for the next years, DOC will show a small growth in Earnings Per Share. The EPS will grow by 1.32% on average per year.
  • DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.02% yearly.
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y1.32%
Revenue Next Year1.33%
Revenue Next 2Y1.76%
Revenue Next 3Y2.62%
Revenue Next 5Y5.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DOC Yearly Revenue VS EstimatesDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
DOC Yearly EPS VS EstimatesDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 47.73, the valuation of DOC can be described as expensive.
  • DOC's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.67. DOC is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 63.27 indicates a quite expensive valuation of DOC.
  • DOC's Price/Forward Earnings ratio is in line with the industry average.
  • DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 47.73
Fwd PE 63.27
DOC Price Earnings VS Forward Price EarningsDOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 69.35% of the companies in the same industry are more expensive than DOC, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DOC indicates a somewhat cheap valuation: DOC is cheaper than 61.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7255.72
EV/EBITDA 13.08
DOC Per share dataDOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.84%
EPS Next 3Y0.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 7.31%, DOC is a good candidate for dividend investing.
  • DOC's Dividend Yield is a higher than the industry average which is at 6.98.
  • Compared to an average S&P500 Dividend Yield of 1.82, DOC pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.31%

5.2 History

  • The dividend of DOC decreases each year by -4.20%.
  • DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
DOC Yearly Dividends per shareDOC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 1204.15% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
DOC Yearly Income VS Free CF VS DividendDOC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B
DOC Dividend Payout.DOC Dividend Payout, showing the Payout Ratio.DOC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HEALTHPEAK PROPERTIES INC

NYSE:DOC (2/6/2026, 1:20:28 PM)

16.705

+0.02 (+0.15%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02
Earnings (Next)04-22
Inst Owners97.22%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change0.5%
Market Cap11.61B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts75.83
Price Target20.27 (21.34%)
Short Float %3.7%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield 7.31%
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)-2.61%
PT rev (3m)-5.03%
EPS NQ rev (1m)-0.82%
EPS NQ rev (3m)0.75%
EPS NY rev (1m)-1.12%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE 47.73
Fwd PE 63.27
P/S 4.11
P/FCF 7255.72
P/OCF 9.27
P/B 1.55
P/tB 1.71
EV/EBITDA 13.08
EPS(TTM)0.35
EY2.1%
EPS(NY)0.26
Fwd EY1.58%
FCF(TTM)0
FCFY0.01%
OCF(TTM)1.8
OCFY10.78%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.94%
ROCE 2.84%
ROIC 2.24%
ROICexc 2.3%
ROICexgc 2.51%
OM 19.31%
PM (TTM) 2.5%
GM 60%
FCFM 0.06%
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 6154.93
Debt/EBITDA 5.92
Cap/Depr 118.09%
Cap/Sales 44.3%
Interest Coverage 2.1
Cash Conversion 78.06%
Profit Quality 2.27%
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 0.32
F-Score6
WACC6.36%
ROIC/WACC0.35
Cap/Depr(3y)91.62%
Cap/Depr(5y)145.43%
Cap/Sales(3y)33.64%
Cap/Sales(5y)52.36%
Profit Quality(3y)87.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y1.32%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.33%
Revenue Next 2Y1.76%
Revenue Next 3Y2.62%
Revenue Next 5Y5.02%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year278.7%
EBIT Next 3Y62.79%
EBIT Next 5Y36.69%
FCF growth 1Y-99.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%

HEALTHPEAK PROPERTIES INC / DOC FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 4 / 10 to DOC.


What is the valuation status for DOC stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.


Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?

HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.


What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 47.73 and the Price/Book (PB) ratio is 1.55.


How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?

The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.